MARKET

BBH

BBH

VanEck Vectors Biotech ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

198.70
-2.18
-1.09%
After Hours: 198.85 +0.15 +0.08% 17:24 06/11 EDT
OPEN
200.54
PREV CLOSE
200.88
HIGH
200.54
LOW
197.88
VOLUME
11.31K
TURNOVER
--
52 WEEK HIGH
201.15
52 WEEK LOW
150.52
TOTAL ASSET
514.54M
YTD YIELD
11.55%
1D
5D
1M
3M
1Y
5Y
ETFs to Win as Moderna Seeks COVID-19 Vaccine Nod for Teens
Zacks.com · 3d ago
5 Top ETFs With Exposure To Biogen
For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA.
Benzinga · 6d ago
Biogen’s Alzheimer’s drug wins FDA approval, see which ETFs are in play
Photo by yalax/iStock via Getty Images The U.S. Food and Drug Administration has approved Biogen (BIIB) and Eisai's Aduhelm (aducanumab) to help treat patients who have Alzheimer's disease. The approval
Seekingalpha · 6d ago
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines
Zacks.com · 05/07 21:00
How Will Biotech ETFs React to These Q1 Earnings Releases?
Zacks.com · 05/06 22:00
Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play
Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground.
Benzinga · 05/06 16:28
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus
Zacks.com · 05/04 20:00
Moderna ETFs to Gain on Positive 'Real-World' Study Data
Zacks.com · 03/30 14:40
More
No Data
Learn about the latest financial forecast of BBH. Analyze the recent business situations of VanEck Vectors Biotech ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-3.3828%
--
1-Week
-1.8228%
--
1-Month
-7.8553%
--
3-Month
-2.1376%
--
6-Month
15.0480%
--
YTD
11.5522%
--
1-Year
28.3810%
--
3-Year
5.0747%
--
5-Year
4.8871%
--
Since Inception
18.9020%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
VanEck Vectors Biotech ETF
Risk
Medium-high risk
Inception Date
2011-12-20
Benchmark
Dow Jones US Healthcare TR
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Liao/Jin